Abstract:Objective:This study aims to investigate the effect of the phosphatidylinositol 3-hydroxy kinase(PI3K)-protein kinase B(AKT)-mammalian target of rapamycin(mTOR) pathway on the drug resistance of osteosarcoma cells and its mechanism to provide new ideas for the targeted therapy of osteosarcoma.Methods:MG-63 cells were cultured in vitro, and MG-63 drug-resistant cell lines were established using the repeated administration of 2 μg/mL cisplatin. The high-expression plasmids of miRNA-22 were transfected into MG-63 drug-resistant cell lines to establish MG-63 drug-resistant cell lines with high miRNA-22 expression. MG-63 cells were the control group, and the MG-63 drug-resistant cells were the drug-resistant group. MG-63 frug-resistant cells treated with 2 μg/mL cisplatin and the drug-resistant MG-63 cells transfected with miRNA-22 were the drug-resistant DDP and the drug-resistant miRNA-22+ DDP groups, respectively. The cell proliferation was detected using the thiazoline (MTT) assay. The expression levels of PI3K, AKT, and mTOR mRNA were detected using fluorescence quantitative RT-PCR. The protein expressions of PI3K, AKT, pAKT, mTOR, and p-mTOR were detected using the Western blot.Results:(1)The MTT results showed that the absorbance values of the control, drug-resistant, drug-resistant DDP, and drug-resistant miRNA-22+ DDP groups were 1.097±0.039, 1.157±0.065, 0.870±0.014, and 0.737±0.029, respectively. The differences were statistically significant ( F=67.731, P<0.01). Compared with that of the control group, the absorbance of the drug-resistant DDP and the drug-resistant miRNA-22+ DDP groups decreased significantly (all P values<0.01). For the drug-resistant, drug-resistant DDP group, and drug-resistant miRNA-22+ DDP group, the absorbance showed a downward trend, and the differences were statistically significant (all P values<0.01). (2)The results of fluorescence quantitative RT-PCR showed that compared with that in the control group, the relative expression of PI3K and AKT in the drug-resistant and the drug-resistant DDP groups increased especially in the drug-resistant group (all P values<0.01). No significant difference was observed between the drug-resistant miRNA-22+ DDP and the control groups (all P values>0.01). The relative expression of mTOR significantly increased in the drug-resistant group and significantly decreased in the drug-resistant DDP and the drug-resistant miRNA-22+ DDP groups (all P values<0.01). The relative expression levels of PI3K, AKT, and mTOR in the drug-resistant DDP and drug-resistant miRNA-22+ DDP groups were lower than those in the drug-resistant group, and all differences were statistically significant (all P values<0.01). The relative expression levels of PI3K and mTOR in the drug-resistant miRNA-22+ DDP group were lower than those in the drug-resistant DDP group, and the differences were statistically significant (all P values<0.01). (3) The results of Western blot showed that compared with that in the control group, the relative expression levels of PI3K, AKT, and mTOR proteins in the drug-resistant group increased significantly and that the relative expression levels of PI3K and AKT proteins in the drug-resistant DDP and drug-resistant miRNA-22+ DDP groups were significantly reduced. The differences were statistically significant (all P values<0.01). The pairwise comparison among three groups revealed that the relative expression levels of PI3K, AKT, and mTOR proteins in the drug-resistant DDP and drug-resistant miRNA-22+ DDP groups were significantly lower than those in the drug-resistant group. The relative expression levels of PI3K and AKT proteins in the drug-resistant miRNA-22+ DDP group were significantly lower than those in the drug-resistant DDP group (all P values<0.01). Conclusions:The PI3K-AKT-mTOR pathway was involved in the development of osteosarcoma cells' resistance to cisplatin. miRNA-22 reduced the resistance of osteosarcoma cells to cisplatin by downregulating the expression levels of PI3K, AKT, and mTOR in the PI3K-AKT-mTOR pathway.

Establishment of a Cisplatin-multidrug Resistance Cell Line of Human Osteosarcoma

Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin.

Establishment And Characterization Of Human Osteosarcoma Cells Resistant To Pyropheophorbide-Alpha Methyl Ester-Mediated Photodynamic Therapy

Cisplatin-resistant Osteosarcoma Cells Possess Cancer Stem Cell Properties in a Mouse Model

Isolation of Stem-Like Cells from Human MG-63 Osteosarcoma Cells Using Limiting Dilution in Combination with Vincristine Selection.

The Inhibitory Effects of Cisplatin-Radiation Combination Treatment on Malignant Osteosarcoma MG-63 Cells and BRCA1-p53 Pathways Are More Efficient Than Single Treatments.

Targeting DNA-PKcs Increased Anticancer Drug Sensitivity by Suppressing DNA Damage Repair in Osteosarcoma Cell Line MG63

Effect of Exogenous P16ink4a and Hrbl Genes on Cell Cycle Regulation of Osteosarcoma Cell Line

Establishment and Biological Characteristics of Oxaliplatin-Resistant Human Colon Cancer Cell Lines.

P-Glycoprotein Overexpression is Associated with Cisplatin Resistance in Human Osteosarcoma

Inhibition of Autophagy Enhances Cisplatin-Induced Apoptosis in the MG63 Human Osteosarcoma Cell Line

Establishment of Orthotopic Model of MG-63 Osteosarcoma

Activation of Unfolded Protein Response Protects Osteosarcoma Cells from Cisplatin-Induced Apoptosis Through NF-κB Pathway.

Effect of the PI3K-AKT-mTOR pathway on the drug resistance of osteosarcoma cells and its mechanism

MicroRNA-504 Modulates Osteosarcoma Cell Chemoresistance to Cisplatin by Targeting P53

Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line

Establishment of a cisplatin-induced human esophageal carcinoma drug-resistant cell line and its biological characteristics

The Synergistic Anticancer Effect of Cisplatin Combined with Oldenlandia Diffusa in Osteosarcoma MG-63 Cell Line in Vitro

Establishment and Characterization of Cisplatin-Resistant Cell Lines from Canine Mammary Gland Tumors.

Establishment and Biological Characters of a Human Osteosarcoma Cell Line SOSP-9607

Effects of combined c-myc and Bmi-1 siRNAs on the growth and chemosensitivity of MG-63 osteosarcoma cells.